Search

Zai Lab Ltd ADR

Chiusa

SettoreSettore sanitario

26.81 3.39

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

25.28

Massimo

26.15

Metriche Chiave

By Trading Economics

Entrata

191K

-51M

Vendite

6.7M

106M

EPS

-0.46

Margine di Profitto

-47.808

Dipendenti

1,784

EBITDA

-2.1M

-46M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+56.67% upside

Dividendi

By Acuity

Utili prossimi

5 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

826M

2.9B

Apertura precedente

23.42

Chiusura precedente

26.81

Notizie sul Sentiment di mercato

By Acuity

50%

50%

160 / 340 Classifica in Healthcare

Zai Lab Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

26 ago 2026, 23:56 UTC

News

Constellation Brands reported first-quarter results that beat expectations, driven by beer sales. The company also reaffirmed EPS guidance and plans a $100 million investment.

26 ago 2026, 23:31 UTC

Correlated Moves
News

The Canadian dollar weakened as Canada imposed $20 billion in tariffs on U.S. goods, contributing to negative sentiment amid ongoing U.S. inflation pressures.

26 ago 2026, 23:31 UTC

News

Interactive Brokers Group shares declined in after-market trading following a Market Perform rating from Raymond James analyst Tim DeLacey. The stock pulled back after earlier gains.

26 ago 2026, 23:26 UTC

News

Zebra Technologies is higher in after-market trading, following its TestMu Conference presentation and analyst estimates valuing shares at $399.00, above the last close of $360.52.

26 ago 2026, 23:21 UTC

News
Social Media

Oppenheimer raised Revolution Medicines' price target to $260, citing FDA approval of RASONQUE for advanced pancreatic cancer, as shares trade higher in after-market hours.

26 ago 2026, 23:16 UTC

Correlated Moves
News

Oracle Corp shares rise in after-market trading following strong fiscal fourth-quarter results, including a 93% increase in cloud-infrastructure revenue to $5.8 billion.

26 ago 2026, 23:06 UTC

News
Social Media

Amazon.com Inc announced a major expansion with Nvidia to deploy 2 million additional GPUs across AWS by 2027-2028, driving shares higher in after-market hours.

26 ago 2026, 23:06 UTC

News
Social Media

Bill Gates emphasized AI risks in a recent essay, urging stronger controls. Microsoft remains roughly flat after deciding against a cloud facility in West Virginia.

26 ago 2026, 23:06 UTC

Correlated Moves
News

Box shares are higher in after-market trading, buoyed by broader market sentiment and Salesforce's significant price movement. Management will present at Citi’s TMT Conference in 2026.

26 ago 2026, 23:06 UTC

Correlated Moves
News

Intuit Inc reported second-quarter revenue of $4.35 billion, exceeding estimates. Shares are trading higher in after-market hours following the results.

26 ago 2026, 23:02 UTC

News
Event

Ooma Inc reported fiscal Q2 revenue of $83.2 million, exceeding estimates. Shares advanced in after-market trading following raised guidance for fiscal 2027.

26 ago 2026, 23:02 UTC

News

Apple Inc shares are lower in after-market hours, reflecting a decline since Wednesday's close amid broader market pressures from PCE price index data.

26 ago 2026, 23:02 UTC

Social Media
Event
Correlated Moves
News

Veeva Systems reported strong Q2 results, raising fiscal 2027 EPS guidance to $9.21. Shares moved higher in after-hours trading following the announcements.

26 ago 2026, 23:02 UTC

News
Social Media

Okta Inc reported strong Q2 results, with revenue of $805 million and adjusted EPS of $1.05, driving shares higher in after-market trading.

26 ago 2026, 23:02 UTC

Social Media
News

Urban Outfitters shares are lower after reporting fiscal Q2 results, with adjusted earnings per share of $1.72 missing estimates of $1.73.

26 ago 2026, 23:02 UTC

Correlated Moves
News

KLA Corp shares are higher in after-market trading, supported by increased demand for process-control systems and positive trends in the semiconductor sector.

26 ago 2026, 23:02 UTC

News

Agilent Technologies reported Q3 revenue of $1.88 billion, exceeding estimates. Shares are trading higher in after-market hours following the raised full-year guidance.

26 ago 2026, 23:02 UTC

Correlated Moves
News
Social Media

Nutanix shares rose in after-hours trading following strong fourth-quarter results, with revenue of $757.1 million and adjusted EPS of $0.60 exceeding estimates.

26 ago 2026, 23:02 UTC

News
Social Media
Event

NVIDIA Corp's stock rose in after-market trading after reporting Q2 revenue of $96.22 billion, exceeding estimates, and providing strong Q3 guidance.

26 ago 2026, 23:02 UTC

News

Union Pacific and Norfolk Southern assert merger compliance with STB standards, presenting evidence of public benefits. Shares are trading higher in after-market hours.

26 ago 2026, 23:02 UTC

Correlated Moves
News

Corning Inc's shares rise in after-market trading, supported by overall market strength and a positive options market outlook. The Nasdaq 100 Index also increased.

26 ago 2026, 23:02 UTC

News
Social Media

CrowdStrike Holdings reported second-quarter revenue of $1.47 billion, exceeding expectations. The stock moved higher in after-market trading following strong guidance and record ARR.

26 ago 2026, 23:02 UTC

News
Social Media

Salesforce Inc reported second-quarter earnings of $5.90 per share, exceeding estimates. The company raised fiscal 2027 revenue guidance, driving shares higher in after-market trading.

26 ago 2026, 23:02 UTC

Correlated Moves
Social Media
News

Tenable Holdings will join the S&P SmallCap 600 effective August 31, boosting investor interest and contributing to higher after-market trading.

26 ago 2026, 23:02 UTC

News
Social Media
Event

Synopsys shares fell in after-hours trading despite strong Q3 results and raised full-year guidance, reflecting investor disappointment over limited upside potential.

26 ago 2026, 23:02 UTC

Event
News
Social Media

HP Inc. shares fell in after-hours trading following fiscal Q3 results, which showed net earnings declining to $661 million despite revenue growth to $15.7 billion.

26 ago 2026, 23:02 UTC

Correlated Moves
News

Lam Research Corp broke ground on a new R&D facility in Oregon, part of a $3 billion expansion plan, as shares rise in after-market trading.

26 ago 2026, 23:02 UTC

News

Lumen Technologies expands Multi-Cloud Gateway access to over 10 million U.S. locations. Shares are trading higher in after-market hours following the announcement.

26 ago 2026, 23:02 UTC

Correlated Moves
Social Media
News

BWX Technologies will deploy its Advanced Nuclear Reactor technology for the U.S. Army's Janus program, with shares rising in after-market trading.

26 ago 2026, 23:01 UTC

News

Verra Mobility Corp expanded its technology partnership with Hertz through a renewed five-year contract. Shares are trading higher in after-market hours.

Confronto tra pari

Modifica del prezzo

Zai Lab Ltd ADR Previsione

Obiettivo di Prezzo

By TipRanks

56.67% in crescita

Previsioni per 12 mesi

Media 41 USD  56.67%

Alto 45 USD

Basso 37 USD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Zai Lab Ltd ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

2 ratings

2

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

160 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat